Innovative ETFs ChannelGreater Regulatory Scrutiny Could Weigh on Biotech ETFsBy Max ChenMarch 24, 2021
Innovative ETFs ChannelIllumina Earnings, Forward Guidance Strengthen Biotech ETFsBy Max ChenFebruary 12, 2021
Innovative ETFs ChannelBiotechnology ETFs Soar on Biogen’s New Alzheimer’s DrugBy Max ChenJanuary 29, 2021
ETF Building Blocks ChannelALPS ‘SBIO’ ETF: Trial Progress Meets Investing SuccessBy Tom LydonJanuary 25, 2021
ETF Building Blocks ChannelDon’t Miss Out on Rampant Biotech Mergers with the SBIO ETFBy Tom LydonJanuary 13, 2021
FeaturedModerna Helps Biotech ETFs Mitigate Massive Losses as Stocks TumbleBy Ian YoungJanuary 4, 2021
FeaturedAs U.K. Authorizes Pfizer Vaccine, Biotech ETFs Continue to RallyBy Ian YoungDecember 3, 2020
ETF Building Blocks ChannelHow Increased FDA Activity Can Benefit ETFs in Your PortfolioBy Tom LydonNovember 19, 2020
Equity ETF ChannelBiotech ETFs Poised for Gains after Moderna Vaccine NewsBy Ian YoungNovember 16, 2020
